HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Matrixx Zicam Chews, Spray, Tablets Expand Brand From Nose To Mouth

This article was originally published in The Tan Sheet

Executive Summary

Matrixx Initiatives is looking to broaden the appeal of its Zicam zinc-based cold remedy line with the debut of three new oral delivery forms slated to hit shelves in time for the next cough/cold season

You may also be interested in...

NACDS In Brief

Matrixx Initiatives: Six-product Concentrated Cough Mist cough supressant line featuring dextromethorphan in spray bottles debuted at the National Association of Chain Drugstores Marketplace in San Diego June 21-24. The four adult products include cool cherry-flavored "Plus D" containing phenylephrine and "Nite" with 10% alcohol for sleep, as well as two single-active offerings in cool cherry and honey lemon. Two SKUs for children include the single-active and Plus D, both in cool cherry. All six products are offered in a 0.75 oz. metered spray bottle and will carry an SRP of $7.99 when they launch in early fall at food, drug and mass outlets. The spray bottle offers a novel drug delivery method in a dye-free, no-stain form allowing consumers to avoid the measuring, spilling and mess associated with syrups, Matrixx says. National TV ads are slated to run along with Zicam brand ads during the 2004 cough/cold season. Matrixx expressed an interest in moving to new oral delivery forms last year (1"The Tan Sheet" May 5, 2003, p. 7)...

Matrixx Zicam Swabs, Other Extensions Slated For September

Matrixx Initiatives, formerly Gum Tech International, is introducing a novel delivery vehicle to the OTC cough/cold remedy market - Zicam Cold Remedy Swabs

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts